Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.

What would we like to know, and what do we not know about fibroblast growth factor 23?

Cozzolino M, Galassi A, Apetrii M, Covic A.

J Nephrol. 2011 Nov-Dec;24(6):696-706. doi: 10.5301/jn.5000003. Review.

PMID:
21786227
2.

FGF23: a key player in mineral and bone disorder in CKD.

Komaba H, Fukagawa M.

Nefrologia. 2009;29(5):392-6. doi: 10.3265/Nefrologia.2009.29.5.5400.en.full. Review.

3.

The fibroblast growth factor 23: a new player in the field of cardiovascular, bone and renal disease.

Cozzolino M, Mazzaferro S.

Curr Vasc Pharmacol. 2010 May;8(3):404-11. Review.

PMID:
20180772
4.

FGF23: its role in renal bone disease.

Fukagawa M, Kazama JJ.

Pediatr Nephrol. 2006 Dec;21(12):1802-6. Epub 2006 Aug 24. Review.

PMID:
16932898
5.
6.

[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD].

Komaba H.

Clin Calcium. 2010 Jul;20(7):1028-36. doi: CliCa100710281036. Review. Japanese.

PMID:
20585181
7.

Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.

Gutiérrez OM.

Clin J Am Soc Nephrol. 2010 Sep;5(9):1710-6. doi: 10.2215/CJN.02640310. Epub 2010 May 27. Review.

9.

New insights into the role of fibroblast growth factor 23 in chronic kidney disease.

Nakai K, Komaba H, Fukagawa M.

J Nephrol. 2010 Nov-Dec;23(6):619-25. Review.

PMID:
20658451
10.

[Pathophysiology of secondary hyperparathyroidism: the role of FGF23 and Klotho].

Mazzaferro S, Pasquali M, Tartaglione L, Rotondi S, Pirrò G.

G Ital Nefrol. 2009 Nov-Dec;26 Suppl 49:S11-7. Italian.

PMID:
19941273
11.

Regulation of parathyroid function in chronic kidney disease (CKD).

Fukagawa M, Nakanishi S, Fujii H, Hamada Y, Abe T.

Clin Exp Nephrol. 2006 Sep;10(3):175-9. Review.

PMID:
17009074
12.

Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.

Koizumi M, Komaba H, Fukagawa M.

Contrib Nephrol. 2013;180:110-23. doi: 10.1159/000346791. Epub 2013 May 3. Review.

PMID:
23652554
13.
14.

Fibroblast growth factor 23 in chronic kidney disease: New insights and clinical implications.

Damasiewicz MJ, Toussaint ND, Polkinghorne KR.

Nephrology (Carlton). 2011 Mar;16(3):261-8. doi: 10.1111/j.1440-1797.2011.01443.x. Review.

PMID:
21265930
15.

FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.

Desjardins L, Liabeuf S, Renard C, Lenglet A, Lemke HD, Choukroun G, Drueke TB, Massy ZA; European Uremic Toxin (EUTox) Work Group..

Osteoporos Int. 2012 Jul;23(7):2017-25. doi: 10.1007/s00198-011-1838-0. Epub 2011 Nov 23.

PMID:
22109743
16.

[FGF23 in chronic kidney disease and kidney post-transplant patients].

Negri A.

Nefrologia. 2009;29(3):196-202. doi: 10.3265/Nefrologia.2009.29.3.5290.en.full. Review. Spanish.

17.

Role of fibroblast growth factor 23 in health and in chronic kidney disease.

Fukagawa M, Nii-Kono T, Kazama JJ.

Curr Opin Nephrol Hypertens. 2005 Jul;14(4):325-9. Review.

PMID:
15930999
18.

[Kidney and bone update : the 5-year history and future of CKD-MBD. CKD-MBD and phosphotropic hormones].

Fukumoto S.

Clin Calcium. 2012 Jul;22(7):987-91. doi: CliCa1207987991. Review. Japanese.

PMID:
22750930
19.

Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease.

Quarles LD.

Exp Cell Res. 2012 May 15;318(9):1040-8. doi: 10.1016/j.yexcr.2012.02.027. Epub 2012 Mar 7. Review.

20.

Role of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism.

Kazama JJ, Gejyo F, Shigematsu T, Fukagawa M.

Ther Apher Dial. 2005 Aug;9(4):328-30. Review.

PMID:
16076376

Supplemental Content

Support Center